Through a grant to the Indiana Legal Services, Anthem has expanded access to free legal services to all Medicaid patients in 18 counties in Central Indiana to assist with housing, employment, and child support issues.
Despite a couple of flaws, Alex Gibney’s new film – airing March 18 – expertly portrays how Elizabeth Holmes’s dream of changing the world of lab testing became a fraud.
A new report looks back on some of the notable tech M&A deals and IPOs that punctuated the worlds of healthcare and biotech, legal, finance, and cybersecurity in 2018 and the outlook for those deals this year.
Reuters reported Monday that the maker of OxyContin was considering the filing so that it could negotiate claims with plaintiffs in about 2,000 lawsuits regarding the drug.
Physicians considering expanding into telemedicine must understand the applicable legal limits, as well as critical ways to minimize their risk.
Rep. Mark Meadows issued a referral for criminal investigation over Michael Cohen’s contacts with Novartis and Kazakhstan’s BTA Bank.
The Senate Finance Committee grilled executives from seven of the biggest drugmakers about the dramatic rise in drug costs.
Judge Mark Wolf denied Optum’s request for a temporary restraining order that would have stopped ex-executive Dave Smith from joining the healthcare venture.
The first company to win regulatory approval for a gene therapy in the U.S. has become the latest acquisition by a large pharmaceutical firm.
According to ABJ COO Jack Stoddard, the initial focus of the collaborative is gathering data and researching the levers that drive costs and prices in healthcare.